Author

M. P. Paralkar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

A. J. Struck· 1 shared A. Margolin· 1 shared A. Nellore· 1 shared A. Nguyen· 1 shared B. A. Christiansen· 1 shared B. Osipov· 1 shared C. M. Ripplinger· 1 shared F. Zhao· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. J. Struck

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PhysiologybioRxivPreprintFeb 20, 2020

Systemic Bone Loss Following Myocardial Infarction in Mice is Mitigated by Treatment with a β3 Adrenergic Receptor Antagonist

P. M. Tjandra, M. P. Paralkar, B. Osipov…·B. A. Christiansen

This study shows that myocardial infarction causes systemic bone loss in mice, which is partially prevented by β3-adrenergic receptor antagonist treatment.

DOI 10.1101/2020.02.20.958116

mouseimaging

𝕏 PostBluesky

Cancer BiologyBMC CancerPeer-reviewedApr 13, 2018

Population-level distribution and putative immunogenicity of cancer neoepitopes

M. A. Wood, M. Paralkar, M. P. Paralkar…·R. F. Thompson

The paper introduces four metrics to prioritize neoepitopes based on peptide novelty and evaluates their immunogenicity using TCGA and melanoma patient data.

DOI 10.1186/s12885-018-4325-6

humanwhole-genome sequencing

𝕏 PostBluesky